Thursday, April 03, 2008 8:22:48 AM
Thursday April 3, 8:00 am ET
KISSIMMEE, Fla., April 3, 2008 /PRNewswire-FirstCall/ -- Thermage, Inc. (Nasdaq: THRM - News) today announced that physician investigators will be presenting clinical research using Thermage technology during the 28th Annual Conference for the American Society for Laser Medicine & Surgery (ASLMS), from both the podium and during a Thermage organized symposium featuring leading experts in the field.
Topics covered during the meeting include advances in skin tightening technology, clinical outcomes using the deep contouring tip for Body Shape procedures and the new treatment for cellulite. Additionally research will be presented on how Thermage technology may be applied for future applications such as fat reduction.
Thermage technology will be featured in the following sessions:
-- Anne C. Chapas, M.D., Skin Rejuvenation Session April 3rd
8 a.m. - 12 p.m.
-- Robert A. Weiss, M.D. Skin Rejuvenation Session April 3rd
8 a.m. - 12 p.m.
-- Christopher Zachary, M.D. "Effects of Monopolar Radiofrequency on the
subcutaneous fat layer in an animal model", Cutaneous Laser Surgery
Session April 6th 8.55 a.m.
Clinical studies accepted as poster presentations include:
-- Sofia Rubbani, M.D. "Advances in Monopolar Radiofrequency for the
treatment of stretch marks in the arms, thighs and abdomens"
-- Neil Saddick, M.D "Immediate effect of a new monopolar radiofrequency
treatment tip on cellulite"
The Thermage Symposium will be held on Thursday April 3rd at 7pm at the Gaylord Palms Resort, Osceola B. The symposium will be moderated by Jeffrey Dover, M.D and will feature Robert Weiss, M.D, Karyn Grossman, M.D and Suzanne Bruce, M.D. The symposium will cover how continual innovation has maintained Thermage technology as the gold standard in skin tightening and contouring for face and body. There will also be a discussion on how Thermage technology and these new applications can be integrated into an aesthetic practice.
"Thermage is dedicated to continual innovation to expand our platform with new applications and to drive the efficacy and value of our products to meet the needs of our customers," said Stephen J. Fanning, Chairman of the Board, President and Chief Executive Officer at Thermage. "The clinical findings being presented at ASLMS are a testament to our commitment to commercialize products that are based on thorough scientific and clinical research as well as our long-standing partnerships with pre-eminent researchers and practitioners in the field."
Recent THRM News
- Gentherm Wins 2024 Automotive News PACE Innovation Partnership Award • GlobeNewswire Inc. • 04/30/2024 12:00:00 PM
- Gentherm Reports 2024 First Quarter Results • GlobeNewswire Inc. • 04/30/2024 10:00:00 AM
- Gentherm Announces Date for 2024 First Quarter Results News Release and Conference Call • GlobeNewswire Inc. • 04/10/2024 08:30:00 PM
- Gentherm Releases 2023 Sustainability Report • GlobeNewswire Inc. • 04/01/2024 08:30:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/07/2024 09:36:07 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 03/05/2024 10:37:00 PM
- Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 02/21/2024 09:44:54 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/21/2024 11:10:16 AM
- Gentherm Reports 2023 Fourth Quarter and Full Year Results • GlobeNewswire Inc. • 02/21/2024 11:00:00 AM
- Gentherm’s ClimateSense® Technology Named a Winner of the 2024 BIG Innovation Award • GlobeNewswire Inc. • 02/16/2024 01:00:00 PM
- Form SC 13G - Statement of acquisition of beneficial ownership by individuals • Edgar (US Regulatory) • 02/09/2024 04:21:57 PM
- Gentherm Announces Date for 2023 Fourth Quarter and Year-End Results News Release and Conference Call • GlobeNewswire Inc. • 01/25/2024 09:45:00 PM
- SourceMark Medical Announces Expanded Partnership with Gentherm Medical • PR Newswire (US) • 01/09/2024 03:00:00 PM
- Gentherm Unveils WellSense™ “A Symphony of Sensations” during CES 2024 • GlobeNewswire Inc. • 01/08/2024 09:30:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/07/2023 09:21:45 PM
- Form 3 - Initial statement of beneficial ownership of securities • Edgar (US Regulatory) • 12/07/2023 09:14:51 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/06/2023 01:30:29 PM
- Gentherm Announces Laura Kowalchik as New Independent Director • GlobeNewswire Inc. • 12/06/2023 01:00:00 PM
- Gentherm Named a Winner of The Michigan Top Workplaces 2023 Award by The Detroit Free Press • GlobeNewswire Inc. • 11/20/2023 01:00:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/02/2023 12:16:00 PM
- Gentherm Initiates $60 Million Accelerated Share Repurchase • GlobeNewswire Inc. • 11/02/2023 12:00:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/26/2023 10:10:13 AM
- Gentherm Reports 2023 Third Quarter Results • GlobeNewswire Inc. • 10/26/2023 10:00:00 AM
- Gentherm’s ClimateSense® Technology Named a Winner of the Reuters D.R.I.V.E Honour for Reducing Emissions • GlobeNewswire Inc. • 10/24/2023 12:00:00 PM
- Gentherm to Participate in the 2023 Baird Global Industrial Conference • GlobeNewswire Inc. • 10/17/2023 12:00:00 PM
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM